Results 141 to 150 of about 85,245 (197)

Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on patient consent and shared decision‐making for blood transfusion

British Journal of Haematology, EarlyView.
The key points to be discussed with a patient when obtaining consent to transfusion are the reason for the transfusion, the benefits and risks of transfusion, the possible alternatives to transfusion, the process for transfusion, any specific transfusion requirements that the patient may have, the consequences of refusing transfusion and the ability to
Michael F. Murphy, Damien Carson, Anwen Davies, Stephanie Ditcham, Graham Donald, Roger Graham, Lizzie Hutchinson, Paul Kerr, Denise McKeown, John Moppett, Shruthi Narayan, Paolo Polzella, Ella Poppitt, Megan Rowley, Tracey Shackleton, Julie Staves, James Neuberger   +16 more
wiley   +1 more source

Empagliflozin combined with bortezomib in the treatment of heavy and light chain amyloidosis with secondary diabetes: A case report. [PDF]

Medicine (Baltimore)
Zhang N, Zhang N, Luo L, Li Y, Ji C, Yuan C.   +5 more
europepmc   +1 more source

Mesenchymal Stem Cell Therapy for Perianal Crohn's Disease: Surgical Appraisal of Evidence and Translational Potential

ANZ Journal of Surgery, EarlyView.
Rathin Gosavi, Charlotte Keung, Gregory Moore, T. C. Nguyen, William Teoh, Raymond Yap, Paul McMurrick, Vignesh Narasimhan   +7 more
wiley   +1 more source

Graft‐versus‐host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post‐transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation

British Journal of Haematology, EarlyView.
Summary The graft‐versus‐leukaemia effect (GVL) is closely associated with graft‐versus‐host disease (GVHD) after human leucocyte antigen (HLA)‐matched allogeneic stem‐cell transplantation (SCT) in acute lymphoblastic leukaemia (ALL). However, there are no data on this association following haploidentical SCT (haploSCT) with post‐transplant ...
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, Alida Dominietto, Mariya Koc, Mutlu Arat, Johanna Tischer, Simona Sica, Zafer Gülbas, Gerard Socié, Didier Blaise, Pietro Pioltelli, Hakan Ozdogu, Jan Vydra, Fabio Ciceri, Arnon Nagler, Mohamad Mohty   +16 more
wiley   +1 more source

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial. [PDF]

Gut Microbes
Groenewegen B, Ruissen MM, Crossette E, Menon R, Prince AL, Norman JM, Ballieux BEPB, Lamb HJ, Terveer EM, Keller JJ, Tushuizen ME.   +10 more
europepmc   +1 more source

Outcomes of Periosteal-Iliac Bone Autografting with Platelet-Rich Plasma in Patients with Hepple V Talar Lesions: A Retrospective Study. [PDF]

Med Sci Monit
Xu Y.
europepmc   +1 more source

From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy. [PDF]

Stem Cell Res Ther
Bozorgi V, Babaahmadi M, Salehi M, Vafaeimanesh J, Hajizadeh-Saffar E.   +4 more
europepmc   +1 more source

Emerging role of G protein‐coupled receptor class C group 5 member D‐directed immunotherapy in multiple myeloma: Advances, resistance and combination strategies

British Journal of Haematology, EarlyView.
Summary Multiple myeloma (MM) is a clonal malignancy of plasma cells characterized by frequent relapse and therapeutic resistance. G protein‐coupled receptor class C group 5 member D (GPRC5D) has emerged as a promising immunotherapeutic target due to its high and selective expression in MM cells and minimal presence in normal tissues.
Xueting Wang, Yushan Cui, Yaomei Wang, Baijun Fang   +3 more
wiley   +1 more source

Human Pluripotent Stem Cell-Based Therapies for Parkinson's Disease: Challenges and Potential Solutions. [PDF]

Yonsei Med J
Chang MY, Lee SH.
europepmc   +1 more source

Towards a chemo‐free approach for follicular lymphoma

British Journal of Haematology, EarlyView.
Summary The therapeutic landscape of follicular lymphoma (FL) is undergoing a transformative shift driven by the advent of novel chemo‐free strategies that challenge the traditional chemo‐oriented paradigms; this shift offers promising alternatives for both newly diagnosed and relapsed or refractory (RR) patients.
Stefano Luminari, Emiliano Barbieri, Maria Elena Nizzoli   +2 more
wiley   +1 more source